Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2011-01-18
2011-01-18
Reddig, Peter J (Department: 1642)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S388250, C530S388800, C530S388850, C530S391100, C530S391300, C435S007100, C435S007920
Reexamination Certificate
active
07872104
ABSTRACT:
This invention concerns an antibody which binds with high affinity to human single-chain intact, i.e. not internally cleaved, mature and/or zymogen forms of prostate specific antigen (SCINT PSA). The antibody does not bind to a nicked PSA (PSA-N), wherein said PSA-N has been formed by internal peptide bond cleavage(s) of SCINT PSA resulting in two-chain or multi-chain PSA. This invention further concerns an immunoassay and a method for differentiating patients with cancer of the prostate (PCa) from patients with benign prostatic hyperplasia (BPH) and/or healthy male subjects without PCa, patients with aggressive PCa from patients with indolent PCa and/or patients with clinically localized and/or organ confined PCa from patients with extraprostatic extension of PCa and/or PCa with metastatic spread to lymph nodes or bone marrow using said antibody.
REFERENCES:
patent: 5858685 (1999-01-01), Stamey et al.
patent: 6143509 (2000-11-01), Dowell et al.
patent: 6423503 (2002-07-01), Mikolajczyk et al.
patent: 6482599 (2002-11-01), Mikolajczyk et al.
patent: 7211397 (2007-05-01), Mikolajczyk et al.
patent: 7659073 (2010-02-01), Mikolajczyk et al.
patent: 2002/0045198 (2002-04-01), Mikolajczyk et al.
patent: WO 98/49323 (1998-11-01), None
patent: WO 00/66718 (2000-11-01), None
Chu, LF et al. Journal of Urology 161: 2009-2012, 1999.
Wang, TJ et al. Eur. J. Biochem. 267: 4040-4045, 2000.
Nurmikko et al. Clinical Chemistry 46(10): 1610-1618, 2000.
Wang, TJ et al. Tumor Biology 20, Suppl. 1, 79-85, 1999.
Chen et al (J. Urol., 157: 2166-2170, 1997).
Harlow and Lane (Antibodies, a Laboratory Manual, Cold Spring Harbor Laboratory Press, 1988, p. 141-142).
Leinonen, J. et al. (1999). “Reactivity of 77 Antibodies to Prostate-Specific Antigen with Isoenzymes and Complexes of Prostate-Specific Antigen,”Tumor Biol. 20 (Suppl. 1), pp. 28-34.
Paus, E. et al. (1999). “Epitope Mapping and Affinity Estimation of 83 Antibodies Against Prostate-Specific Antigen,”Tumor Biol. 20 (Suppl. 1), pp. 52-69.
Nurmikko, P. et al. (2000). “Production and Characterization of Novel Anti-Prostate-Specific Antigen (PSA) Monoclonal Antibodies That Do Not Detect Internally Cleaved Lys145-Lys146 Inactive PSA,”Clinical Chem. 46:10, pp. 1610-1618.
Wang, T.J. et al. (2000). “Benign Prostatic Hyperplasia-Associated Prostate-Specific Antigen (BPSA) Shows Unique Immunoreactivity With Anti-PSA Monoclonal Antibodies,”Eur. J. Biochem. 267, pp. 4040-4045.
Lilja Hans
Lövgren Timo
Niemelä Pauliina
Pettersson Kim
Arctic Partners Oy AB
Reddig Peter J
Rothwell, Figg Ernst & Manbeck, PC
LandOfFree
Antibody, immunoassay and method for prostate cancer detection does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibody, immunoassay and method for prostate cancer detection, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibody, immunoassay and method for prostate cancer detection will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2740208